baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BVT Knock-Out PGR/ DE000VD75WP9 /

30/08/2024 21:37:50	Chg.+0.16	Bid22:00:36	Ask22:00:36	Underlying	Strike price	Expiration date	Option type
4.16EUR	+4.00%	- Bid Size: -	- Ask Size: -	Progressive Corporat...	207.19 USD	31/12/2078	Call

GlobeNewswire 19/08 Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa

GlobeNewswire 19/08 Tiziana Life Sciences Appoints New Chief Executive Officer

GlobeNewswire 19/08 Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...

GlobeNewswire 19/08 CN Issues Lockout Notice to Teamsters

GlobeNewswire 15/08 Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...

GlobeNewswire 14/08 Progressive Reports July 2024 Results

GlobeNewswire 14/08 Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene ...

GlobeNewswire 14/08 Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule

GlobeNewswire 13/08 Eyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

GlobeNewswire 12/08 Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Newsfile Corp 12/08 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

TeleTrader 11/08 Bank of Russia says rates could reach 20%

GlobeNewswire 08/08 Opthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15,...

GlobeNewswire 08/08 Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th

GlobeNewswire 07/08 Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Sus...

GlobeNewswire 07/08 AGS Unveils its Latest Table Innovation Bonus Spin Xtreme for Poker Rooms and an Exciting New Lineup...

GlobeNewswire 07/08 Team, Inc. Announces Timing of Second Quarter Earnings Release and Conference Call

TeleTrader 07/08 Cori Bush loses Missouri Democratic primary

GlobeNewswire 06/08 TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy)...

GlobeNewswire 06/08 Levicept Announces Positive Results of Phase II Trial of novel Neurotrophin-3 Inhibitor, LEVI-04, fo...

TeleTrader 06/08 Aramco's Q2 net income down 3.2% to $29.1 billion

GlobeNewswire 05/08 Progressive Announces Quarterly Common Share Dividend

GlobeNewswire 05/08 NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted...

GlobeNewswire 05/08 Annexon Provides Update on ARCHER II Global Registrational Program in Geographic Atrophy

GlobeNewswire 30/07 Progressive Announces Investor Relations Event

BVT Knock-Out PGR/ DE000VD75WP9 /

If you wish to receive reply to your feedback, please provide your email address.